A mathematical model reveals the influence of population heterogeneity on herd immunity to SARS-CoV-2

Infectious Diseases of Humans: Dynamics and Control

(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-2-174_4 · Cited by 7,819

Infectious Diseases of Humans: Dynamics and Control

Anderson, R. M., & May, R. M. (1991) · doi:10.1093/oso/9780198545996.001.0001 · Cited by 6,179

Epidemic Spreading in Scale-Free Networks

Pastor‐Satorras, R., & Vespignani, A. (2001) · Physical Review Letters · doi:10.1103/physrevlett.86.3200 · Cited by 5,785

Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand

Ferguson, N. M., Laydon, D. J., Nedjati-Gilani, G. L., Imai, N., Ainslie, K. E. C., Baguelin, M., Bhatia, S., Boonyasiri, A., Cucunubá, Z. M., Cuomo-Dannenburg, G., et al. (2020) · Spiral (Imperial College London) · doi:10.25561/77482 · Cited by 3,619

Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe

Flaxman, S. R., Mishra, S., Gandy, A., Unwin, H. J. T., Mellan, T. A., Coupland, H., Whittaker, C., Zhu, H., Berah, T., Eaton, J. W., et al. (2020) · Nature · doi:10.1038/s41586-020-2405-7 · Cited by 3,398

Estimating the burden of SARS-CoV-2 in France

Salje, H., Tran Kiem, C., Lefrancq, N., Courtejoie, N., Bosetti, P., Paireau, J., Andronico, A., Hozé, N., Richet, J., Dubost, C.-L., et al. (2020) · Science · doi:10.1126/science.abc3517 · Cited by 1,038

Stochastic Epidemic Models and Their Statistical Analysis

Andersson, H., & Britton, T. (2000) · Lecture notes in statistics · doi:10.1007/978-1-4612-1158-7 · Cited by 906

Using Data on Social Contacts to Estimate Age-specific Transmission Parameters for Respiratory-spread Infectious Agents

Wallinga, J., Teunis, P. F. M., & Kretzschmar, M. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj317 · Cited by 702

Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe

Flaxman, S. R., Mishra, S., Gandy, A., Unwin, H. J. T., Mellan, T. A., Coupland, H., Whittaker, C., Zhu, H., Berah, T., Eaton, J. W., et al. (2020) · Spiral (Imperial College London) · doi:10.25561/77731 · Cited by 632

Mathematical Tools for Understanding Infectious Disease Dynamics

Diekmann, O., Heesterbeek, H., & Britton, T. (2012) · Princeton University Press eBooks · doi:10.23943/princeton/9780691155395.001.0001 · Cited by 365

COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates

Sallam, M. (2021) · Vaccines · doi:10.3390/vaccines9020160 · Cited by 2,128

COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries

(2021) · doi:10.1038/s41591-021-01454-y · Cited by 1,105

COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey

Sherman, S. M., Smith, L., Sim, J., Amlôt, R., Cutts, M., Dasch, H. K., Rubin, G. J., & Sevdalis, N. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1846397 · Cited by 748

Infection fatality rate of COVID-19 inferred from seroprevalence data

Ioannidis, J. P. A. (2021) · Bulletin of the World Health Organization · doi:10.2471/blt.20.265892 · Cited by 684

COVID-19 herd immunity: where are we?

Fontanet, A. L., & Cauchemez, S. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-00451-5 · Cited by 552

Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination

Anderson, R. M., Vegvari, C., Truscott, J., & Collyer, B. S. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32318-7 · Cited by 529

Non-pharmaceutical interventions during the COVID-19 pandemic: A review

Perra, N. (2021) · Physics Reports · doi:10.1016/j.physrep.2021.02.001 · Cited by 540

Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic

Buss, L. F., Prete, C. A., Abrahim, C. M. M., Mendrone, A., Salomon, T., de Almeida-Neto, C., França, R. F. O., Belotti, M. C., Carvalho, M. P. S. S., Costa, A. G., et al. (2021) · Science · doi:10.1126/science.abe9728 · Cited by 488

Public acceptance of COVID-19 vaccines: cross-national evidence on levels and individual-level predictors using observational data

Lindholt, M. F., Jørgensen, F. J., Bor, A., & Petersen, M. B. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-048172 · Cited by 350

Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold

Gomes, M. G. M., Ferreira, M. U., Corder, R. M., King, J. G., Souto-Maior, C., Penha‐Gonçalves, C., Gonçalves, G., Chikina, M. D., Pegden, W., & Aguas, R. J. (2022) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2022.111063 · Cited by 344

Exhaled CO 2 as a COVID-19 Infection Risk Proxy for Different Indoor Environments and Activities

Peng, Z., & Jimenez, J. L. (2021) · Environmental Science & Technology Letters · doi:10.1021/acs.estlett.1c00183 · Cited by 337

Hesitancy Toward a COVID-19 Vaccine

Thunström, L., Ashworth, M., Finnoff, D., & Newbold, S. C. (2020) · EcoHealth · doi:10.1007/s10393-021-01524-0 · Cited by 299

The changing epidemiology of SARS-CoV-2

Koelle, K., Martin, M. A., Antia, R., Lopman, B. A., & Dean, N. E. (2022) · Science · doi:10.1126/science.abm4915 · Cited by 308

Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years

Saad-Roy, C. M., Wagner, C. E., Baker, R. E., Morris, S. E., Farrar, J., Graham, A. L., Levin, S. A., Mina, M. J., Metcalf, C. J. E., & Grenfell, B. T. (2020) · Science · doi:10.1126/science.abd7343 · Cited by 283

Cross-reactive memory T cells and herd immunity to SARS-CoV-2

Lipsitch, M., Grad, Y. H., Sette, A., & Crotty, S. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-00460-4 · Cited by 260

Transparent communication about negative features of COVID-19 vaccines decreases acceptance but increases trust

Petersen, M. B., Bor, A., Jørgensen, F. J., & Lindholt, M. F. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2024597118 · Cited by 240

Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes

Saad-Roy, C. M., Morris, S. E., Metcalf, C. J. E., Mina, M. J., Baker, R. E., Farrar, J., Holmes, E. C., Pybus, O. G., Graham, A. L., Levin, S. A., et al. (2021) · Science · doi:10.1126/science.abg8663 · Cited by 221

Optimal Control of the COVID-19 Pandemic with Non-pharmaceutical Interventions

Perkins, T. A., & España, G. (2020) · Bulletin of Mathematical Biology · doi:10.1007/s11538-020-00795-y · Cited by 200

Global perspective of COVID‐19 epidemiology for a full‐cycle pandemic

Ioannidis, J. P. A. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13423 · Cited by 198

SARS-CoV-2 Antibody Prevalence in India: Findings from the Second Nationwide Household Serosurvey, August - September 2020

Murhekar, M. V., Bhatnagar, T., Selvaraju, S., Saravanakumar, V., Thangaraj, J. W. V., Shah, N. K., Kumar, M. S., Rade, K., Sabarinathan, R., Asthana, S., et al. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30544-1 · Cited by 190

COVID-19 vaccine literacy and vaccine hesitancy among pregnant women and mothers of young children in Japan

Takahashi, Y. K., Ishitsuka, K., Sampei, M., Okawa, S., Hosokawa, Y., Ishiguro, A., Tabuchi, T., & Morisaki, N. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.09.094 · Cited by 181

Encouraging COVID-19 Vaccine Uptake Through Effective Health Communication

Motta, M., Sylvester, S. M., Callaghan, T., & Trujillo, K. L. (2021) · Frontiers in Political Science · doi:10.3389/fpos.2021.630133 · Cited by 175

Lancet COVID-19 Commission Statement on the occasion of the 75th session of the UN General Assembly

Sachs, J. D., Abdool Karim, S., Aknin, L., Allen, J., Brosbøl, K., Cuevas Barron, G., Daszak, P., Espinosa, M. F., Gaspar, V., Gaviria, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31927-9 · Cited by 171

Swedish policy analysis for Covid-19

Kavaliūnas, A., Ocaya, P., Mumper, J., Lindfeldt, I., & Kyhlstedt, M. (2020) · Health Policy and Technology · doi:10.1016/j.hlpt.2020.08.009 · Cited by 159

COVID-19: Rethinking the Lockdown Groupthink

Joffe, A. R. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.625778 · Cited by 163

SARS-CoV-2 (COVID-19) superspreader events

Majra, D., Benson, J., Pitts, J. M., & Stebbing, J. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.11.021 · Cited by 155

Can a COVID-19 vaccine live up to Americans’ expectations? A conjoint analysis of how vaccine characteristics influence vaccination intentions

Motta, M. (2021) · Social Science & Medicine · doi:10.1016/j.socscimed.2020.113642 · Cited by 151

Seroprevalence of SARS-CoV-2 in slums versus non-slums in Mumbai, India

Malani, A., Shah, D., Kang, G., Lobo, G. N., Shastri, J. S., Mohanan, M., Jain, R. K., Agrawal, S. R., Juneja, S., Imad, S., et al. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30467-8 · Cited by 150

Behavioral dynamics of COVID ‐19: estimating underreporting, multiple waves, and adherence fatigue across 92 nations

Rahmandad, H., Lim, T. Y., & Sterman, J. D. (2021) · System Dynamics Review · doi:10.1002/sdr.1673 · Cited by 150

Association of Simulated COVID-19 Vaccination and Nonpharmaceutical Interventions With Infections, Hospitalizations, and Mortality

Patel, M. D., Rosenstrom, E., Ivy, J. S., Mayorga, M. E., Keskinocak, P., Boyce, R. M., Lich, K. H., Smith, R., Johnson, K., Delamater, P. L., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.10782 · Cited by 140

Short-term predictions and prevention strategies for COVID-19: A model-based study

Nadim, S. S., Ghosh, I., & Chattopadhyay, J. (2021) · Applied Mathematics and Computation · doi:10.1016/j.amc.2021.126251 · Cited by 133

Evidence that coronavirus superspreading is fat-tailed

Wong, F. J., & Collins, J. J. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2018490117 · Cited by 138

Estimating the reproductive number R0 of SARS-CoV-2 in the United States and eight European countries and implications for vaccination

Ke, R., Romero-Severson, E. O., Sanche, S., & Hengartner, N. (2021) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2021.110621 · Cited by 131

Information about herd immunity through vaccination and empathy promote COVID-19 vaccination intentions.

Pfattheicher, S., Petersen, M. B., & BOHM, R. M. (2021) · Health Psychology · doi:10.1037/hea0001096 · Cited by 119

Overdispersion in COVID-19 increases the effectiveness of limiting nonrepetitive contacts for transmission control

Sneppen, K., Nielsen, B. F., Taylor, R. J., & Simonsen, L. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2016623118 · Cited by 119

Acceptance of COVID-19 vaccines in sub-Saharan Africa: evidence from six national phone surveys

Kanyanda, S., Markhof, Y. V., Wollburg, P. R., & Zezza, A. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-055159 · Cited by 115

Key questions for modelling COVID-19 exit strategies

Thompson, R. N., Hollingsworth, T. D., Isham, V. S., Arribas‐Bel, D., Ashby, B., Britton, T., Challenor, P., Chappell, L. H. K., Clapham, H., Cunniffe, N. J., et al. (2020) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2020.1405 · Cited by 111

The Approach of Pregnant Women to Vaccination Based on a COVID-19 Systematic Review

Januszek, S., Faryniak-Zuzak, A., Barnaś, E., Łoziński, T., Góra, T., Siwiec, N., Szczerba, P., Januszek, R., & Kluz, T. (2021) · Medicina · doi:10.3390/medicina57090977 · Cited by 111

An Economist’s Guide to Epidemiology Models of Infectious Disease

Avery, C. N., Bossert, W. H., Clark, A., Ellison, G., & Ellison, S. F. (2020) · The Journal of Economic Perspectives · doi:10.1257/jep.34.4.79 · Cited by 108

Coronavirus herd immunity optimizer with greedy crossover for feature selection in medical diagnosis

Alweshah, M., Alkhalaileh, S., Al‐Betar, M. A., & Bakar, A. A. (2021) · Knowledge-Based Systems · doi:10.1016/j.knosys.2021.107629 · Cited by 108

COVID-19 Superspreading Suggests Mitigation by Social Network Modulation

Nielsen, B. F., Simonsen, L., & Sneppen, K. (2021) · Physical Review Letters · doi:10.1103/physrevlett.126.118301 · Cited by 108

Genomic reconstruction of the SARS-CoV-2 epidemic in England

Vöhringer, H. S., Sanderson, T., Sinnott, M., Maio, N. D., Nguyen, T., Goater, R., Schwach, F., Harrison, I., Hellewell, J., Ariani, C. V., et al. (2021) · Nature · doi:10.1038/s41586-021-04069-y · Cited by 108

Hesitant or Not Hesitant? A Systematic Review on Global COVID-19 Vaccine Acceptance in Different Populations

Salomoni, M. G., Valerio, Z. D., Gabrielli, E., Montalti, M., Tedesco, D., Guaraldi, F., & Gori, D. (2021) · Vaccines · doi:10.3390/vaccines9080873 · Cited by 102

Swift and extensive Omicron outbreak in China after sudden exit from ‘zero-COVID’ policy

Goldberg, E. E., Lin, Q., Romero-Severson, E. O., & Ke, R. (2023) · Nature Communications · doi:10.1038/s41467-023-39638-4 · Cited by 101

Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis

(2021) · doi:10.1016/j.vaccine.2021.04.002 · Cited by 101

Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, Qatar

Jeremijenko, A., Chemaitelly, H., Ayoub, H. H., Alishaq, M., Abou-Samra, A.-B., Al Ajmi, J. A. A. A., Al Ansari, N. A. A., Al Kanaani, Z., Al Khal, A., Al Kuwari, E., et al. (2021) · Emerging Infectious Diseases · doi:10.3201/eid2705.204365 · Cited by 97

Neural heterogeneity controls computations in spiking neural networks

Gast, R., Solla, S. A., & Kennedy, A. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2311885121 · Cited by 105

Gender, socioeconomic status, and COVID‐19 vaccine hesitancy in the US: An intersectionality approach

Morales, D. X., Beltran, T. F., & Morales, S. A. (2022) · Sociology of Health & Illness · doi:10.1111/1467-9566.13474 · Cited by 105

Herd immunity thresholds for SARS-CoV-2 estimated from unfolding epidemicsPreprint

Aguas, R. J., Gonçalves, G., Ferreira, M. U., & Gomes, M. G. M. (2020) · medRxiv · doi:10.1101/2020.07.23.20160762 · Cited by 99

Time-dependent heterogeneity leads to transient suppression of the COVID-19 epidemic, not herd immunity

Tkachenko, A. V., Maslov, S., Elbanna, A. E., Wong, G. N., Weiner, Z. J., & Goldenfeld, N. D. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2015972118 · Cited by 98

Forecasting COVID-19 and Analyzing the Effect of Government Interventions

Li, M. L., Bouardi, H. T., Lami, O. S., Trikalinos, T. A., Trichakis, N., & Bertsimas, D. (2022) · Operations Research · doi:10.1287/opre.2022.2306 · Cited by 92

The importance of non-pharmaceutical interventions during the COVID-19 vaccine rollout

Gozzi, N., Bajardi, P., & Perra, N. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009346 · Cited by 95

SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals

Coyle, P. V., Chemaitelly, H., Ben Hadj Kacem, M. A., Abdulla Al Molawi, N. H., El Kahlout, R. A., Gilliani, I., Younes, N., Al Anssari, G. A. A. A., Al Kanaani, Z., Al Khal, A., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102646 · Cited by 86

SARS-CoV-2 Infection Is at Herd Immunity in the Majority Segment of the Population of Qatar

Al-Thani, M. H., Farag, E., Bertollini, R., Al Romaihi, H. E., Abdeen, S., Abdelkarim, A., Daraan, F., Elhaj Ismail, A. I. H., Mostafa, N., Sahl, M., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab221 · Cited by 85

Mathematical modeling and optimal intervention strategies of the COVID-19 outbreak

Mondal, J., & Khajanchi, S. (2022) · Nonlinear Dynamics · doi:10.1007/s11071-022-07235-7 · Cited by 84

Optimal timing of one-shot interventions for epidemic control

Lauro, F. D., Kiss, I. Z., & Miller, J. C. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008763 · Cited by 81

Chopping the tail: How preventing superspreading can help to maintain COVID-19 control

Kain, M. P., Childs, M. L., Becker, A. D., & Mordecai, E. A. (2020) · Epidemics · doi:10.1016/j.epidem.2020.100430 · Cited by 82

The effect of COVID-19 on the economy: Evidence from an early adopter of localized lockdowns

Asahi, K., Undurraga, E. A., Valdés, R., & Wagner, R. A. (2021) · Journal of Global Health · doi:10.7189/jogh.10.05002 · Cited by 78

Human mobility and poverty as key drivers of COVID-19 transmission and control

Yechezkel, M., Weiss, A., Rejwan, I., Shahmoon, E., Ben-Gal, S., & Yamin, D. (2021) · BMC Public Health · doi:10.1186/s12889-021-10561-x · Cited by 86

COVID-19 Vaccine Booster Dose Acceptance: Systematic Review and Meta-Analysis

Abdelmoneim, S. A., Sallam, M., Hafez, D. M., Elrewany, E. M. A., Mousli, H. M., Hammad, E. M., Elkhadry, S. W., Adam, M. F., Ghobashy, A. A., Naguib, M., et al. (2022) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed7100298 · Cited by 81

COVID-19 healthcare demand and mortality in Sweden in response to non-pharmaceutical mitigation and suppression scenarios

Sjödin, H., Johansson, A. F., Brännström, Å., Farooq, Z., Kriit, H. K., Wilder‐Smith, A., Åström, C., Thunberg, J., Söderquist, M., & Rocklöv, J. (2020) · International Journal of Epidemiology · doi:10.1093/ije/dyaa121 · Cited by 80

Socio-demographic and health factors drive the epidemic progression and should guide vaccination strategies for best COVID-19 containment

Markovič, R., Šterk, M., Marhl, M., Perc, M., & Gosak, M. (2021) · Results in Physics · doi:10.1016/j.rinp.2021.104433 · Cited by 81

COVID-19 Vaccine Hesitancy in the LGBTQ+ Population: A Systematic Review

Garg, I., Hanif, H., Javed, N., Abbas, R., Mirza, S. A., Javaid, M. A., Pal, S., Shekhar, R., & Sheikh, A. B. (2021) · Infectious Disease Reports · doi:10.3390/idr13040079 · Cited by 77

Kinetic models for epidemic dynamics with social heterogeneity

Dimarco, G., Benoît Perthame, B., Toscani, G., & Zanella, M. (2021) · Journal of Mathematical Biology · doi:10.1007/s00285-021-01630-1 · Cited by 85

Acceptance of COVID-19 Vaccines in Sub-Saharan Africa : Evidence from Six National Phone SurveysPreprint

Kanyanda, S. S. E., Markhof, Y. V., Wollburg, P. R., & Zezza, A. (n.d.) · RePEc: Research Papers in Economics · Cited by 74

COVID-19 vaccines: concerns beyond protective efficacy and safety

Lai, C., Chen, I., Chao, C., Lee, P., Ko, W., & Hsueh, P. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1949293 · Cited by 72

High SARS-CoV-2 seroprevalence in children and adults in the Austrian ski resort of Ischgl

Knabl, L., Mitra, T., Kimpel, J., Rössler, A., Volland, A., Walser, A., Ulmer, H., Pipperger, L., Binder, S. C., Riepler, L., et al. (2021) · Communications Medicine · doi:10.1038/s43856-021-00007-1 · Cited by 70

Herd immunity

Ashby, B., & Best, A. (2021) · Current Biology · doi:10.1016/j.cub.2021.01.006 · Cited by 68

Leveraging epidemiological principles to evaluate Sweden’s COVID-19 response

Baral, S., Chandler, R. E., Prieto, R. G., Gupta, S., Mishra, S., & Kulldorff, M. (2020) · Annals of Epidemiology · doi:10.1016/j.annepidem.2020.11.005 · Cited by 67

State of the Art in Adoption of Contact Tracing Apps and Recommendations Regarding Privacy Protection and Public Health: Systematic Review

Kolasa, K., Mazzi, F., Leszczuk-Czubkowska, E., Zrubka, Z., & Péntek, M. (2021) · JMIR mhealth and uhealth · doi:10.2196/23250 · Cited by 65

A review of mathematical model-based scenario analysis and interventions for COVID-19

Padmanabhan, R., Abed, H. S., Meskin, N., Khattab, T. M., Shraim, M., & Al-Hitmi, M. A. E. (2021) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2021.106301 · Cited by 65

Vaccine rollout strategies: The case for vaccinating essential workers early

Mulberry, N., Tupper, P. F., Kirwin, E. M., McCabe, C. J., & Colijn, C. (2021) · PLOS Global Public Health · doi:10.1371/journal.pgph.0000020 · Cited by 67

Clinical outcomes and cost-effectiveness of COVID-19 vaccination in South Africa

Reddy, K. P., Fitzmaurice, K. P., Scott, J. A., Harling, G., Lessells, R. J., Panella, C., Shebl, F. M., Freedberg, K. A., & Siedner, M. J. (2021) · Nature Communications · doi:10.1038/s41467-021-26557-5 · Cited by 62

A Continuous Markov-Chain Model for the Simulation of COVID-19 Epidemic Dynamics

Xu, Z., Zhang, H., & Huang, Z. J. (2022) · Biology · doi:10.3390/biology11020190 · Cited by 58

An Empiricist’s Guide to Using Ecological Theory

Grainger, T. N., Senthilnathan, A., Ke, P., Barbour, M. A., Jones, N. T., DeLong, J. P., Otto, S. P., O’Connor, M. I., Coblentz, K. E., Goel, N., et al. (2021) · The American Naturalist · doi:10.1086/717206 · Cited by 64

Modeling COVID-19 dynamic using a two-strain model with vaccination

de León, U. A.-P., Avila-Vales, E. J., & Huang, K. (2022) · Chaos Solitons & Fractals · doi:10.1016/j.chaos.2022.111927 · Cited by 59

Vaccination Acceptance Across Cultures: The Roles of Collectivism, Empathy, and Homophily

Leonhardt, J. M., & Pezzuti, T. (2021) · Journal of International Marketing · doi:10.1177/1069031x211073179 · Cited by 56

Population-based seroprevalence of SARS-CoV-2 and the herd immunity threshold in Maranhão

da Sílva, A. A. M., Neto, L. G. L., de Azevedo, C. D. M. P. E. S., da Costa, L. M. M., Bragança, M. L. B. M., Filho, A. K. D. B., Wittlin, B. B., de Souza, B. F., de Oliveira, B. L. C. A., de Carvalho, C. A., et al. (2020) · Revista de Saúde Pública · doi:10.11606/s1518-8787.2020054003278 · Cited by 57

Exploring optimal control of epidemic spread using reinforcement learning

Ohi, A. Q., Mridha, M. F., Monowar, M. M., & Hamid, M. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-79147-8 · Cited by 55

The gut microbiome as a biomarker of differential susceptibility to SARS-CoV-2

Sarkar, A., Harty, S., Moeller, A. H., Klein, S. L., Erdman, S. E., Friston, K. J., & Carmody, R. N. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.09.009 · Cited by 56

Stochastic social behavior coupled to COVID-19 dynamics leads to waves, plateaus, and an endemic state

Tkachenko, A. V., Maslov, S., Wang, T., Elbana, A., Wong, G. N., & Goldenfeld, N. D. (2021) · eLife · doi:10.7554/elife.68341 · Cited by 58

Impact of a New SARS-CoV-2 Variant on the Population: A Mathematical Modeling Approach

González‐Parra, G., Martínez‐Rodríguez, D., & Villanueva, R. J. (2021) · Mathematical and Computational Applications · doi:10.3390/mca26020025 · Cited by 55

Accumulation of Immunity in Heavy-Tailed Sexual Contact Networks Shapes Mpox Outbreak Sizes

Murayama, H., Pearson, C. A. B., Abbott, S., Miura, F., Jung, S.-M., Fearon, E., Funk, S., & Endo, A. (2023) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiad254 · Cited by 53

Cellular immune responses to covid-19

Sewell, H. F., Agius, R. M., Stewart, M., & Kendrick, D. (2020) · BMJ · doi:10.1136/bmj.m3018 · Cited by 53

SARS-CoV-2 transmission, persistence of immunity, and estimates of Omicron’s impact in South African population cohorts

Sun, K., Tempia, S., Kleynhans, J., von Gottberg, A., McMorrow, M. L., Wolter, N., Bhiman, J. N., Moyes, J., du Plessis, M., Carrim, M., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abo7081 · Cited by 52

Herd Immunity to SARS-CoV-2 among the Population in Saint-Petersburg during the COVID-19 Epidemic

Popova, A. Y., Ezhlova, E. B., Melnikova, A. A., Bashketova, N. S., Фридман, Р., Lyalina, L. V., Смирнов, В. С., Chkhindzheriya, I. G., Grechaninova, T. A., Agapov, K. A., et al. (2020) · Problems of Particularly Dangerous Infections · doi:10.21055/0370-1069-2020-3-124-130 · Cited by 52

SARS-CoV-2 viral load peaks prior to symptom onset: a systematic review and individual-pooled analysis of coronavirus viral load from 66 studiesPreprint

Benefield, A. E., Skrip, L., Clement, A., Althouse, R. A., Chang, S. T., & Althouse, B. M. (2020) · medRxiv · doi:10.1101/2020.09.28.20202028 · Cited by 55

Estimating COVID-19 under-reporting across 86 nations: implications for projections and controlPreprint

Rahmandad, H., Lim, T. Y., & Sterman, J. D. (2020) · medRxiv · doi:10.1101/2020.06.24.20139451 · Cited by 55

Test for Covid-19 seasonality and the risk of second waves

Engelbrecht, F. A., & Scholes, R. J. (2020) · One Health · doi:10.1016/j.onehlt.2020.100202 · Cited by 53

Commentary on the use of the reproduction number R during the COVID-19 pandemic

Vegvari, C., Abbott, S., Ball, F., Brooks‐Pollock, E., Challen, R., Collyer, B. S., Dangerfield, C. E., Gog, J. R., Gostic, K. M., Heffernan, J. M., et al. (2021) · Statistical Methods in Medical Research · doi:10.1177/09622802211037079 · Cited by 51

Covid-19 no nordeste do Brasil: entre o lockdown e o relaxamento das medidas de distanciamento social

Ximenes, R. A. D. A., de Albuquerque, M. D. F. P. M., Martelli, C. M. T., de Araújo, T. V. B., Miranda-Filho, D. D. B., de Souza, W. V., Ichihara, M. Y., de Lira, P. I. C., Kerr, L. R. F. S., Aquino, E. M. L., et al. (2021) · Ciência & Saúde Coletiva · doi:10.1590/1413-81232021264.39422020 · Cited by 50

Power-law population heterogeneity governs epidemic waves

Neipel, J., Bauermann, J., Bo, S., Harmon, T. S., & Jülicher, F. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239678 · Cited by 51

Willingness of the general population to accept and pay for COVID-19 vaccination during the early stages of COVID-19 pandemic: a nationally representative survey in mainland China

Zhang, Y., Luo, X., & Feei, Z. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1847585 · Cited by 49

SARS-CoV-2 population-based seroprevalence studies in Europe: a scoping review

Grant, R., Dub, T., Andrianou, X. D., Nohynek, H., Wilder‐Smith, A., Pezzotti, P., & Fontanet, A. L. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-045425 · Cited by 49

Cultural and social attitudes towards COVID-19 vaccination and factors associated with vaccine acceptance in adults across the globe: A systematic review

Begum, T., Efstathiou, N., Bailey, C., & Guo, P. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.05.041 · Cited by 49

Which Beliefs Predict Intention to Get Vaccinated against COVID-19? A Mixed-Methods Reasoned Action Approach Applied to Health Communication

Lueck, J. A., & Spiers, A. (2020) · Journal of Health Communication · doi:10.1080/10810730.2020.1865488 · Cited by 48

Estimates of global SARS-CoV-2 infection exposure, infection morbidity, and infection mortality rates in 2020

Ayoub, H. H., Mumtaz, G. R., Seedat, S., Makhoul, M., Chemaitelly, H. S., & Abu-Raddad, L. J. (2021) · Global Epidemiology · doi:10.1016/j.gloepi.2021.100068 · Cited by 48

Overcoming COVID-19 Vaccine Hesitancy: Insights from an Online Population-Based Survey in the United States

Badr, H., Zhang, X., Oluyomi, A. O., Woodard, L., Adepoju, O. E., Raza, S. A., & Amos, C. I. (2021) · Vaccines · doi:10.3390/vaccines9101100 · Cited by 46

Taking a machine learning approach to optimize prediction of vaccine hesitancy in high income countries

Lincoln, T. M., Schlier, B., Strakeljahn, F., Gaudiano, B. A., So, S. H., Kingston, J. L., Morris, E. M. J., & Ellett, L. (2022) · Scientific Reports · doi:10.1038/s41598-022-05915-3 · Cited by 46

County-level Predictors of Coronavirus Disease 2019 (COVID-19) Cases and Deaths in the United States: What Happened, and Where Do We Go from Here?

McLaughlin, J. M., Khan, F. L., Pugh, S. J., Angulo, F. J., Schmitt, H., Istúriz, R., Jódar, L., & Swerdlow, D. L. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1729 · Cited by 47

Heterogeneity and herd immunity

Ash, C. (2020) · Science · doi:10.1126/science.369.6505.783-o

Mathematical assessment of the roles of age heterogeneity and vaccination on the dynamics and control of SARS-CoV-2

Pant, B. P., & Gumel, A. B. (2024) · Infectious Disease Modelling · doi:10.1016/j.idm.2024.04.007 · Cited by 8

Data-driven estimate of SARS-CoV-2 herd immunity threshold in populations with individual contact pattern variationsPreprint

Lu, D. Z., Aleta, A., Ajelli, M., Pastor‐Satorras, R., Vespignani, A., & Moreno, Y. (2021) · medRxiv · doi:10.1101/2021.03.19.21253974 · Cited by 13

Power-law population heterogeneity governs epidemic waves

Neipel, J., Bauermann, J., Bo, S., Harmon, T. S., & Jülicher, F. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239678 · Cited by 51

SARS-CoV-2 infection and herd immunity: A public health perspective

Saleem, S. M., & Sharma, G. A. (2020) · doi:10.18231/j.ijirm.2020.029